Rex Medical Announces the Successful Retrieval of the Option Vena Cava Filter up to Day 225 in an International Clinical Study

Rex Medical, L.P., announced the successful retrieval of the Option(TM) Vena Cava Filter in an international clinical study after implantation up to 225 days. A total of thirty patients were enrolled and have been successfully implanted with the Option(TM) Filter for the prevention of Pulmonary Embolism (PE) resulting from blood clots or "Deep Vein Thrombosis" (DVT) under the direction of Adrian A. Ebner, MD, Chief of Interventional Procedures and Cardiovascular Surgery, French Hospital, Asuncion, Paraguay. PE occurs when thromboemboli (or "blood clots") become dislodged from the deep veins located in the legs and travel through the blood stream to the lungs. If left untreated, PE has a...

Want to see the full article?

• Purchase this article for only $3.00